ACT Genomics Establishes NGS Laboratory to Offer Comprehensive Cancer Genomic Profiling Service in Japan

2019-04-19

ACTmed, a joint venture between Canon Medical Systems Corporation and ACT Genomics  has established an analysis laboratory named "Shonan iPark Laboratory" in "Shonan Health Innovation Park". With the laboratory, ACTmed will offer precision cancer medicine to fulfill the clinical needs and drug development activities in Japan, making it possible to provide comprehensive services to quickly address requests from clients and promptly respond to their inquiries. Full-scale operation is scheduled to commence in July 2019.

Full text:

https://www.prnewswire.com/news-releases/act-genomics-establishes-ngs-laboratory-to-offer-comprehensive-cancer-genomic-profiling-service-in-japan-300834581.html?tc=eml_cleartime